Carna Biosciences (TSE:4572) Other Operating Expense : 円2,434 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Other Operating Expense?

Carna Biosciences's Other Operating Expense for the three months ended in Mar. 2024 was 円550 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円2,434 Mil.

Carna Biosciences's quarterly Other Operating Expense increased from Sep. 2023 (円508 Mil) to Dec. 2023 (円778 Mil) but then declined from Dec. 2023 (円778 Mil) to Mar. 2024 (円550 Mil).

Carna Biosciences's annual Other Operating Expense increased from Dec. 2021 (円2,413 Mil) to Dec. 2022 (円2,485 Mil) and increased from Dec. 2022 (円2,485 Mil) to Dec. 2023 (円2,568 Mil).

Carna Biosciences Other Operating Expense Historical Data

The historical data trend for Carna Biosciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Other Operating Expense Chart

Carna Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

2,022.06

1,998.26

2,413.28

2,485.09

2,567.57

Carna Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															684.13	597.46	507.82	778.17	550.44

Carna Biosciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,434 Mil.

Carna Biosciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences (TSE:4572) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines